Home › NDC Lookup › Ingredients › Dextroamphetamine Saccharate, Amphetamin... › 00115-1491-01
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg Capsule, 100-count — NDC 00115-1491-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg Capsule, 100-count — NDC 0115-1491-01 (Billing 00115-1491-01)

by Amneal Pharmaceuticals of New York LLC · 100 CAPSULE in 1 BOTTLE

This is a package of 100 capsules of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg Capsule from Amneal Pharmaceuticals of New York LLC, marketed since Feb 2016 and currently FDA-listed; retail pharmacies pay about $0.4656 per capsule (NADAC). It is this product's only package size.

NDC 00115-1491-01
🏷️ FDA NDC (as labeled) 0115-1491-01 billing pads the labeler segment with a zero
Rx only Generic On market CII ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0115-1491-01 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
0115 labeler · 1491 product · 01 package
Package marketed since
Feb 16, 2016
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 0115149101 4
Medicaid fills, this package
85,128 prescriptions in the last four reported quarters
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0115-1491-01
Product NDC 0115-1491
11-digit billing NDC 00115149101
NCPDP billing unit EA — each (per item)
Application # ANDA076852
SPL Set ID ce289645-272b-4036-a807-2077a3927e9f
Established class (EPC) Central Nervous System Stimulant; Central Nervo
Physiologic effect Central Nervous System Stimulation
DEA schedule CII
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2016-02-16
Route ORAL
Dosage form CAPSULE
Substance DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE ASPARTATE MONOHYDRATE; DEXTROAMPHETAMINE SULFATE; AMPHETAMINE SULFATE
TE code (Orange Book) AB1 · RLD · RS

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 61109902107030
GCN Seq No 048703
GCN 14637
HICL code 013449
Ingredient (HICL) Dextroamphetamine/Amphetamine
HIC1 code J
Therapeutic class — broad (HIC1) Autonomic Nervous System
HIC2 code J5
Therapeutic class — intermediate (HIC2) Adrenergics
HIC3 code J5B
Therapeutic class — specific (HIC3) Adrenergics, Aromatic, Non-Catecholamine
AHFS code 28:20.04.00
AHFS class Amphetamines
FDB label name DEXTROAMP-AMPHET ER 30 MG CAP
FDB brand name Dextroamphetamine-Amphet Er
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 048703
  • GCN: 14637
  • GPI-14 (Medi-Span): 61109902107030
  • HICL (First Databank): 013449
  • AHFS class code: 28:20.04.00
Why two NDCs? The FDA registers this code as 0115-1491-01 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00115-1491-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name DEXTROAMP-AMPHET ER 30 MG CAP Ingredient Dextroamphetamine/Amphetamine
📖 What it is MedlinePlus · NLM

The combination of dextroamphetamine and amphetamine (Adderall®, Adderall® XR, Mydayis®) is used as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age). Adderall® is used to treat ADHD in adults and children 3 years of age and older. Adderall® XR is used to treat ADHD in adults and children 6 years of age and older. Mydayis® is used to treat ADHD in adults and children 13 years of age and older. Dextroamphetamine and amphetamine (Add...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It treats ADHD. Some tablet products, including Adderall tablets, are also used for narcolepsy. Which product you have determines the approved ages and uses.
  • Extended-release capsules are usually taken once a day in the morning, because they can last up to 16 hours and may disturb sleep. Take it the same way each day, with or without fo...
  • Loss of appetite, trouble sleeping, stomach pain, nervousness and weight loss are common. Adults may also get dry mouth and headache. Call your doctor if these are bothersome or se...
  • It has a high potential for abuse and misuse, which can lead to addiction and overdose. Take only as prescribed, never share it, store it locked up, and dispose of leftovers safely...
📖 Read our full Amphetamine / Amphetamine Aspartate / Dextroamphetamine / Dextroamphetamine Saccharate guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.466 $46.56 / 100 capsules
Medicaid paysCMS SDUD · 12 mo $0.9405 $94.05 / 100 capsules
Medicare drug plans payPart D · Q2 2026 $1.09 $109.32 / 100 capsules
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.660 $0.462
▼ Down 22% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00115-1491-01 You're viewing this Main listing 100 CAPSULE in 1 BOTTLE 2016-02-16 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mgthis 00115-1491-01 Amneal 100 capsules $0.466 AB1 Availability likely —
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg 00228-3061-11 Actavis 100 capsules $0.466 AB1 Availability likely —
Mixed Salts of a Single Entity Amphetamine Product XR 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg 00406-8956-01 SpecGx 100 capsules $0.466 AB1 Availability likely —
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg 00527-0795-37 Lannett 100 capsules $0.466 AB1 Availability likely —
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg 31722-0195-01 Camber 100 capsules $0.466 AB1 Availability likely —
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg 35573-0469-02 Burel 100 capsules $0.466 AB1 Availability likely —
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg 42858-0930-01 Rhodes 100 capsules $0.466 AB1 Availability likely —
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg 43975-0282-10 ANI 100 capsules $0.466 AB1 Availability likely —
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg 64850-0515-01 Elite 100 capsules $0.466 AB1 Availability likely —
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg 66993-0599-02 Prasco 100 capsules $0.466 AB1 Availability likely —
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg 70010-0034-01 Granules 100 capsules $0.466 AB1 Availability likely —
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg 00781-2371-01 Sandoz 100 capsules $0.559 AB1 FDA listed +20%
Adderall XR 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg 54092-0391-01 Takeda 100 capsules $6.808 AB1 Availability likely +1362%
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg 51407-0562-01 Golden 100 capsules — AB1 FDA listed —
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg 63629-1977-01 Bryant 100 capsules — AB1 FDA listed —
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg 72162-1381-01 Bryant 100 capsules — AB1 FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2016
On the market since
Feb 2016
📍
2026
Currently FDA-listed
10 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color brown / turquoise / white
ShapeCapsule
ImprintG456
Size21 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Amphetamine / Amphetamine Aspartate / Dextroamphetamine / Dextroamphetamine Saccharate inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 5138Q19F1X
    Ammonia is a colorless gas made from nitrogen and hydrogen. It's used in medicines as a pH buffer to maintain the correct acidity level and help keep the product stable.
  • UNII 1K09F3G675
    Ferric oxide red is an inorganic iron compound used as a colorant in medicines. It gives tablets, capsules, or other dosage forms a red or reddish tint for identification and appearance.
  • UNII EX438O2MRT
    Ferric oxide yellow is a naturally occurring iron compound used as a colorant in medications. It gives tablets, capsules, and other forms a yellow or golden hue for identification and appearance.
  • UNII XM0M87F357
    A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
  • UNII 2G86QN327L
    Gelatin is a protein derived from animal collagen, commonly used in medicines as a gelling agent and capsule material. It helps create soft or hard capsule shells that hold and release medication, and can also thicken liquid formulations.
  • UNII 0VUT3PMY82
    Hypromellose 2910 is a plant-derived thickening agent made from cellulose. In medicines, it forms protective coatings on tablets or capsules, controls how fast the drug releases, and thickens liquid formulations.
  • UNII R75537T0T4
    Hypromellose 2910 is a plant-derived thickening agent made from cellulose. It serves as a binder that holds tablet ingredients together, a film-coating for pills, and a viscosity controller in liquids.
  • UNII 1IVH67816N
    Hypromellose 2910 is a plant-derived cellulose compound used as a thickener and film-former in medicines. It helps control how quickly the medication dissolves and creates protective coatings on tablets or capsules.
  • UNII 0WZ8WG20P6
    Hypromellose 2910 is a plant-based cellulose derivative that acts as a thickener, binder, and film-coating agent. It helps control how quickly the medicine dissolves and protects the tablet or capsule from moisture and light.
  • UNII NX76LV5T8J
    A synthetic plastic polymer made from methacrylic acid and ethyl acrylate. It's used as a coating or binder to control how and where the medicine dissolves in your digestive system.
  • UNII VH2XOU12IE
    Polydextrose is a synthetic polymer made from dextrose (sugar) that acts as a bulking agent and filler in medicines. It helps give tablets and capsules proper volume and texture while often adding slight sweetness.
  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
  • UNII WZH3C48M4T
    Potassium hydroxide is a strong alkaline chemical used in medicines to adjust and maintain the pH level of liquid formulations, helping keep the product stable and the active ingredients effective.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII 46N107B71O
    Shellac is a natural resin secreted by the lac beetle. It's used as a coating on tablets and capsules to control how quickly the medicine dissolves and to improve appearance and stability.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
  • UNII C151H8M554
    A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
  • UNII XHX3C3X673
    Triacetin is a clear, oily liquid made from glycerin and acetic acid. It works as a plasticizer and solvent in medicines, helping soften coatings and improve how liquids mix together in formulations.
  • UNII 8Z96QXD6UM
    Triethyl citrate is a clear liquid derived from citric acid. It acts as a plasticizer and solvent in tablet coatings and film formulations, helping the coating remain flexible and adhere properly to the medicine.

21 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAmneal Pharmaceuticals of New York LLC
Application holderIMPAX LABORATORIES INC
FDA applicationANDA076852 (ANDA)
Labeler code00115
First marketedFeb 2016
DEA scheduleCII
Product typeHuman Prescription Drug
Portfolio228 products on file

More NDCs from Amneal Pharmaceuticals of New York LLC labeler code 00115

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
85.1K
Units reimbursed last 4 qtrs
2.8M
Gross reimbursed last 4 qtrs
$2.61M
Avg / prescription
$30.60
Avg / unit
$0.9405
Latest quarter Q1 2026
16.3KRx
Medicaid pays / ea
$0.9405
gross reimbursed
vs
NADAC / ea
$0.4656
acquisition cost
=
Spread
+$0.4749
+102% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
32% FFS 68% MCO
Fee-for-service · 27,456 Rx Managed care · 57,672 Rx
State Medicaid map
Alaska: 2,130 units · 291 per 100k residents AK Maine: 18,438 units · 1,322 per 100k residents ME Washington: 23,946 units · 307 per 100k residents WA Idaho: 9,745 units · 496 per 100k residents ID Montana: 4,740 units · 419 per 100k residents MT North Dakota: 7,829 units · 1,000 per 100k residents ND Minnesota: 91,177 units · 1,589 per 100k residents MN Wisconsin: 43,102 units · 729 per 100k residents WI Michigan: 118,753 units · 1,183 per 100k residents MI New York: 211,918 units · 1,083 per 100k residents NY Vermont: 7,479 units · 1,156 per 100k residents VT New Hampshire: 19,514 units · 1,392 per 100k residents NH Oregon: 31,479 units · 744 per 100k residents OR Nevada: 3,260 units · 102 per 100k residents NV Wyoming: no data reported WY South Dakota: 6,840 units · 744 per 100k residents SD Iowa: 67,068 units · 2,091 per 100k residents IA Illinois: 79,624 units · 635 per 100k residents IL Indiana: 273,710 units · 3,989 per 100k residents IN Ohio: 344,661 units · 2,925 per 100k residents OH Pennsylvania: 296,526 units · 2,288 per 100k residents PA New Jersey: 110,949 units · 1,194 per 100k residents NJ Massachusetts: 12,824 units · 183 per 100k residents MA California: 18,511 units · 47.5 per 100k residents CA Utah: 2,691 units · 78.8 per 100k residents UT Colorado: 58,118 units · 989 per 100k residents CO Nebraska: 18,693 units · 945 per 100k residents NE Missouri: 58,177 units · 939 per 100k residents MO Kentucky: 43,893 units · 970 per 100k residents KY West Virginia: 44,540 units · 2,516 per 100k residents WV Virginia: 118,869 units · 1,364 per 100k residents VA Maryland: 128,367 units · 2,077 per 100k residents MD Connecticut: 86,126 units · 2,381 per 100k residents CT Rhode Island: 46,380 units · 4,236 per 100k residents RI Arizona: 11,670 units · 157 per 100k residents AZ New Mexico: 3,584 units · 170 per 100k residents NM Kansas: 15,483 units · 527 per 100k residents KS Arkansas: 3,263 units · 106 per 100k residents AR Tennessee: 14,551 units · 204 per 100k residents TN North Carolina: 151,733 units · 1,400 per 100k residents NC South Carolina: 54,548 units · 1,015 per 100k residents SC Delaware: 12,189 units · 1,182 per 100k residents DE Oklahoma: 8,839 units · 218 per 100k residents OK Louisiana: 23,533 units · 514 per 100k residents LA Mississippi: 3,824 units · 130 per 100k residents MS Alabama: 5,518 units · 108 per 100k residents AL Georgia: 35,727 units · 324 per 100k residents GA D.C.: 6,360 units · 937 per 100k residents DC Hawaii: no data reported HI Texas: 1,033 units · 3.4 per 100k residents TX Florida: 8,021 units · 35.5 per 100k residents FL
Units reimbursed · per 100k residents
3.44,236
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Rhode Island 4,236 /100k
2 Indiana 3,989 /100k
3 Ohio 2,925 /100k
4 West Virginia 2,516 /100k
5 Connecticut 2,381 /100k
6 Pennsylvania 2,288 /100k
7 Iowa 2,091 /100k
8 Maryland 2,077 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
← 00115-1490-01 · Amneal 00115-1526-08 · Amneal →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.